Media interview
The US FDA recommends USP4 as the dissolution priority test method. Does the Chinese pharmaceutical industry see its value?
How to overcome the difficulties encountered in testing the dissolution of microspheres?
What method will you recommend to test the microsphere dissolution?
What is your opinion on the policy of generic drug consistency evaluation?
How to effectively use the in vitro and in vivo correlation (IVIVC) for the dissolution testing of nanoparticle formulations (e.g., microspheres)?
Found something interesting?
Get better results by talking to an expert!
More essential person in AAPS!
The goal is the reduce the cost for the health care system, because health cost a lot of money. So there are many possible initiatives, one is the “7 + 4 cities in China”, that’s one way to reduce the cost.
Samir HaddouchiManaging Director | SPS Parma Service 
BE-特辑
中国新药研发之路
播放视频
媒体訪問
美国FDA建议USP4为溶出度优先测试方法，中国制药行业有否看到其价值？
如何克服测试微球溶出度时遇到的困难？
--微球溶出度测试方法建议？
对仿制药一致性评价政策的看法？
如何有效地利用体外体内相关性 (IVIVC) 进行纳米粒子剂型 (如微球) 溶出度测试？
找到了有趣的东西？
通过与專家交谈，获得更好的溶出結果！
More essential person in AAPS!
The goal is the reduce the cost for the health care system, because health cost a lot of money. So there are many possible initiatives, one is the “7 + 4 cities in China”, that’s one way to reduce the cost.
Samir HaddouchiManaging Director | SPS Parma Service